Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Thalidomide may stop the growth of cancer by stopping blood flow to the tumor.
Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop
growing or die. Combining thalidomide with docetaxel may kill more tumor cells.
PURPOSE: Phase I trial to study the effectiveness of combining thalidomide with docetaxel in
treating patients who have advanced cancer.